MCP-4 and Eotaxin-3 Are Novel Biomarkers for Chronic Obstructive Pulmonary Disease

MCP-4 and Eotaxin-3 Are Novel Biomarkers for Chronic Obstructive Pulmonary Disease

The aim of our study was to examine the production of monocyte chemoattractant protein (MCP-4) and eotaxin-3 during the onset and progression of COPD. The expression levels of MCP-4 and eotaxin-3 were evaluated in COPD samples and healthy controls using immunostaining and ELISA. The relationship bet...

Full description

Bibliographic Details
Main Authors:	Chun Fang, Baoguo Kang, Pan Zhao, Jing Ran, Lifang Wang, Lingqiong Zhao, Hangyu Luo, Ling Tao
Format:	Article
Language:	English
Published:	Hindawi Limited 2023-01-01
Series:	Canadian Respiratory Journal
Online Access:	http://dx.doi.org/10.1155/2023/8659293

Similar Items

Assessment of eotaxin 1 in exhaled breath condensate of chronic obstructive pulmonary disease patients
by: Gehan Elassal, et al.
Published: (2014-01-01)

Eotaxins and Their Receptor as Biomarkers of Colorectal Cancer
by: Monika Zajkowska, et al.
Published: (2021-06-01)

MCP‐1 and eotaxin‐1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes
by: Brianne M. Bettcher, et al.
Published: (2016-01-01)

Eotaxin-2 and eotaxin-3 in malaria exposure and pregnancy
by: Cristina Mancebo-Pérez, et al.
Published: (2022-11-01)

Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis
by: Takechiyo Yamada, et al.
Published: (2019-02-01)

Increased Eotaxin and MCP-1 Levels in Serum from Individuals with Periodontitis and in Human Gingival Fibroblasts Exposed to Pro-Inflammatory Cytokines.
by: Elisabeth A Boström, et al.
Published: (2015-01-01)

Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema
by: Di Stefano A, et al.
Published: (2018-05-01)

Serum Interleukin-6 and CCL11/Eotaxin May Be Suitable Biomarkers for the Diagnosis of Chronic Nonbacterial Osteomyelitis
by: Sigrun Ruth Hofmann, et al.
Published: (2017-12-01)

Eotaxin levels in patients with primary dysmenorrhea
by: Gul E, et al.
Published: (2018-03-01)

ROLE OF IL-5 AND EOTAXIN IN DEVELOPMENT OF BLOOD EOSINOPHILIC REACTION DURING PULMONARY TUBERCULOSIS
by: U. V. Kolobovnikova, et al.
Published: (2014-07-01)

Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease
by: Comes Alexandra, et al.
Published: (2016-06-01)

From Allergy to Cancer—Clinical Usefulness of Eotaxins
by: Monika Zajkowska, et al.
Published: (2021-01-01)

DNA Methylation: A Potential Biomarker of Chronic Obstructive Pulmonary Disease
by: Lin-Xi He, et al.
Published: (2020-07-01)

Autoantibodies in Chronic Obstructive Pulmonary Disease
by: Lifang Wen, et al.
Published: (2018-01-01)

Adiponectin as inflammatory biomarker of chronic obstructive pulmonary disease
by: Sabah S. Oraby, et al.
Published: (2014-07-01)

Biomarkers in chronic obstructive pulmonary disease: confusing or useful?
by: Stockley RA
Published: (2014-02-01)

Lesional Infiltration of Eosinophils, Basophils, and M2 Macrophages Expressing Eotaxin-1 and Eotaxin-3 in Granuloma Faciale, but not in Erythema Elevatum Diutinum
by: Nozomi Akai, et al.
Published: (2024-02-01)

Role of MCP-1 as an inflammatory biomarker in nephropathy
by: Yanlong Liu, et al.
Published: (2024-01-01)

Eotaxins and Their Receptor in Colorectal Cancer—A Literature Review
by: Monika Zajkowska, et al.
Published: (2020-05-01)

Biomarker-based clustering of patients with chronic obstructive pulmonary disease
by: Lowie E.G.W. Vanfleteren, et al.
Published: (2023-02-01)

EARLY DETECTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE — VECTOR ON BIOMARKERS
by: V. I. Shevcova, et al.
Published: (2016-08-01)

Cardiac biomarkers of prognostic importance in chronic obstructive pulmonary disease
by: Ulf Nilsson, et al.
Published: (2020-06-01)

Two C‐C Family Chemokines, Eotaxin and RANTES, Are Novel Independent Plasma Biomarkers for Abdominal Aortic Aneurysm
by: Gregory T. Jones, et al.
Published: (2016-05-01)

The role of polymorphism of genes eotaxin (–384) and CCR3 (–51) in formation of blood eosinophilia under pulmonary tuberculosis
by: K. O. Miheeva, et al.
Published: (2012-12-01)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
by: Lababidi, R, et al.
Published: (2017)

Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders
by: Antonio L. Teixeira, et al.
Published: (2018-06-01)

Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease
by: Ding Liu, et al.
Published: (2020-09-01)

Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score
by: Megha Hegde, et al.
Published: (2024-03-01)

Pulmonary rehabilitation for patients with chronic obstructive pulmonary disease
by: Cui Zhao, et al.
Published: (2022-11-01)

Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease
by: Keiji Oishi, et al.
Published: (2020-08-01)

From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease
by: Hsu-Hui Wang, et al.
Published: (2021-11-01)

The impact of smoking on inflammatory biomarkers in patients with chronic obstructive pulmonary disease
by: Yasser A. Korani, et al.
Published: (2016-07-01)

Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease
by: Aparna Balasubramanian, et al.
Published: (2021-07-01)

Levels of eotaxin-3 as a noninvasive biomarker for monitoring the treatment EoE in school age children with food allergy
by: Krystyna Stencel-Gabriel, et al.
Published: (2017-04-01)

Serum C-C motif ligand 11/Eotaxin-1 may serve as a candidate biomarker for postmenopausal osteoporosis
by: Wang Wen, et al.
Published: (2019-01-01)

Levels of eotaxin-3 as a noninvasive biomarker for monitoring the treatment EoE in school age children with food allergy
by: Krystyna Stencel-Gabriel, et al.
Published: (2017-04-01)

The gut microbiome as a potential source of non-invasive biomarkers of chronic obstructive pulmonary disease
by: Naijian Li, et al.
Published: (2023-07-01)

Low melting point MCP-69, MCP-96, MCP-137, and MCP-200 alloys for radiation protection in radiological and therapeutic processes
by: Michael W. Perrigin, et al.
Published: (2022-12-01)

TIMP-1: A Circulating Biomarker for Pulmonary Hypertension Diagnosis Among Chronic Obstructive Pulmonary Disease Patients
by: Wenjun He, et al.
Published: (2022-02-01)

The role of platelet-derived growth factor receptor in eotaxin signaling of eosinophils.
by: Adachi, T, et al.
Published: (2006)